Anergic T cells as active regulators of the immune response

Human Immunology

Volumn 61, Issue 7, 2000, Pages 633-639

  Taams, Leonie S ^a   Wauben, Marca H M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Anergy; Heat shock proteins; Immunoregulation; Suppression; Tolerance

Indexed keywords

HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CELLULAR IMMUNITY; CLONAL ANERGY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; CLONAL ANERGY; HUMANS; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 0033947803     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00127-0     Document Type: Review

References (54)

1. Lacour M., Rudolphi U., Schlesier M., Peter H.H. Type II collagen-specific human T cell lines established from healthy donors. Eur J Immunol. 20:1990;931.
2. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183.
3. Ridgway W.M., Weiner H.L., Fathman C.G. Regulation of autoimmune response. Curr Opin Immunol. 6:1994;946.
4. Cohen I.R., Young D.B. Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today. 12:1991;105.
5. Saoudi A., Seddon B., Hetah V., Fowell D., Mason D. The physiological role of regulatory T cells in the prevention of autoimmunity the function of the thymus in the generation of the regulatory T cell subset . Immunol Rev. 149:1996;195.
6. Lafaille J.J., Nagashima K., Katsuki M., Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 78:1994;399.
7. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 184:1996;387.
8. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 16:1995;34.
9. Buer J., Lanoue A., Franzke A., Garcia C., Von Boehmer H., Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med. 187:1998;177.
10. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature. 389:1997;737.
11. + T cell lines. J Exp Med. 185:1997;1769.
12. Weiner H.L. Oral tolerance immune mechanisms and treatment of autoimmune diseases . Immunol Today. 18:1997;335.
13. + T cells induce wasting disease with multiple organ pathology prevention by the OX-22 low subset . J Exp Med. 172:1990;1701.
14. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 155:1995;1151.
15. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol. 160:1998;1212.
16. Brunner M.C., Mitchison N.A., Schneider S.C. Immunoregulation mediated by T cell clusters. Folia Biol. 40:(Praha):1994;359.
17. Mitchison N.A., O'Malley C. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur J Immunol. 17:1987;1579.
18. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747.
19. + T-helper and a T-killer cell. Nature 1998; 393:474.
20. Bennett SRM, Carbone FR, Karamalis F, Flavell RA, Miller JFAP, Heath WR: Help for cytotoxic-T cell responses is mediated by CD40 signalling. Nature 1998; 393: 478.
21. Schoenberger SP, Toes REM, van der Voort EIH, Offringa R, Melief CJM: T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998; 393: 480.
22. Holán V., Mitchison N.A. Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens. Eur J Immunol. 13:1983;652.
23. Davies J.D., Leong L.Y.W., Mellor A., Cobbold S.P., Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol. 156:1996;3602.
24. Qin S., Cobbold S.P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. "Infectious" transplantation tolerance. Science. 259:1993;974.
25. Waldmann H., Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol. 16:1998;619.
26. Marshall S.E., Cobbold S.P., Davies J.D., Martin G.M., Phillips J.M., Waldmann H. Tolerance and suppression in a primed immune system. Transplantation. 62:1996;1614.
27. Waldmann H., Qin S., Cobbold S. Monoclonal antibodies as agents to reinduce tolerance in autoimmunity. J Autoimmun. 5:(Suppl. A):1992;93.
28. Lombardi G., Sidhu S., Batchelor R., Lechler R. Anergic T cells as suppressor cells in vitro. Science. 264:1994;1587.
29. Taams L.S., van Rensen A.J.M.L., Poelen M.C.M., van Els C.A.C.M., Besseling A.C., Wagenaar J.P.A., van Eden W., Wauben M.H.M. Anergic T cells actively suppress T cell responses via the antigen presenting cell. Eur J Immunol. 28:1998;2902.
30. + T cells in vitro. J Virol. 70:1996;7540.
31. Taams LS, Boot EPJ, van Eden W, Wauben MHM: "Anergic" T cells modulate the T cell activating capacity of antigen-presenting cells. J Autoimmun (in press).
32. Miller R.G. The veto phenomenon and T cell regulation. Immunol Today. 7:1986;112.
33. Fink P.J., Shimonkevitz R.P., Bevan M.J. Veto cells. Annu Rev Immunol. 6:1988;115.
34. Mallett S., Fossum S., Barclay A.N. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - a molecule related to nerve growth factor receptor. EMBO J. 9:1990;1063.
35. + T cells. Int Immunol. 10:1998;453.
36. Taams LS, Wauben MHM, van Eden W: Antigen specific immunosuppressive effects of T cells with distinct levels of anergy. In Talwar GP, Nath I, Ganguly NK, Rao KVS (eds): The 10th International Congress of Immunology, Vol 1. New Delhi, India, Monduzzi Editore, 1998.
37. Taams L.S., van Eden W., Wauben M.H.M. Dose-dependent induction of distinct anergic phenotypes multiple levels of T cell anergy . J Immunol. 162:1999;1974.
38. Pichler W.J., Wyss-Coray T. T cells as antigen-presenting cells. Immunol Today. 15:1994;312.
39. LaSalle J.M., Tolentino P.J., Freeman G.J., Nadler L.M., Hafler D.A. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med. 176:1992;177.
40. Arnold P.Y., Davidian D.K., Mannie M.D. Antigen presentation by T cells T cell receptor ligation promotes antigen acquisition from professional antigen presenting cells . Eur J Immunol. 27:1997;3198.
41. Broeren C.P.M., Lucassen M.A., van Stipdonk M.J.B., van der Zee R., Boog C.J.P., Kusters J.G., van Eden W. CDR1 T cell receptor β-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. Proc Natl Acad Sci USA. 91:1994;5997.
42. Hashim G.A., Offner H., Wang R.Y., Shulka K., Carvalho E., Morrison W.J., Vandenbark A.A. Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TcR V 8.2 chain. J Immunol. 149:1992;2803.
43. + T cells in recovery from antigen-induced autoimmune disease. J Exp Med. 178:1993;909.
44. Broeren C.P.M., Lucassen M.A., van Eden W. T cell receptor directed immunoregulation of experimental autoimmune arthritis. Zhang J., Raus J.C.M. Autoimmune Disease and T Cell Vaccination Perspectives on Clonotypic Regulation and Prospects for Therapy . 1995;R. G. Landers Medical Publisher & Co, Austin, TX.
45. van Eden W., Anderton S.M., van der Zee R., Prakken B.J., Broeren C.P.M., Wauben M.H.M. (Altered) self peptides and the regulation of self-reactivity in the peripheral T cell pool. Immunol Rev. 149:1996;55.
46. van Eden W., van der Zee R., Taams L.S., Prakken A.B.J., van Roon J., Wauben M.H.M. Heat-shock protein T cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T cell response. Immunol Rev. 164:1998;169.
47. van Eden W., van der Zee R., Paul A.G.A., Prakken B.J., Wendling U., Anderton S.M., Wauben M.H.M. Do heat shock proteins control the balance of T cell regulation in inflammatory diseases? Immunol Today. 19:1998;303.
48. Anderton S.M., van der Zee R., Prakken B., Noordzij A., van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med. 181:1995;943.
49. Taams L.S., van Eden W., Wauben M.H.M. Antigen presentation by T cells versus professional APC differential consequences for T cell activation and subsequent T cell-APC interactions . Eur J Immunol. 29:1999;1543.
50. + naturally anergic and suppressive T cells induction of autoimmune disease by breaking their anergic/suppressive state . Int Immunol. 10:1998;1969.
51. +CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 188:1998;287.
52. + immunoregulatory T cells is antigen nonspecific. J Immunol. 164:2000;183.
53. Salojin K.V., Zhang J., Madrenas J., Delovitch T.L. T cell anergy and altered T cell receptor signaling effects on autoimmune disease . Immunol Today. 19:1998;468.
54. van Rensen A.J.M.L., Taams L.S., Grosfeld-Stulemeyer M.C., van Eden W., Crommelin D.J.A., Wauben M.H.M. Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes. Pharm Res. 17:2000;720.